← TrialMatch
HomeTrials

Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessati

This clinical trial evaluates the usefulness of using a smartphone-based HIV-specific smoking cessation intervention at the time of lung cancer screening in helping people living with HIV quit smoking. Positively Smoke Free - Mobile may help patients with HIV quit smoking.

Condition(s)HIV Infection, Tobacco-Related Carcinoma
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryThis clinical trial evaluates the usefulness of using a smartphone-based HIV-specific smoking cessation intervention at the time of lung cancer screening in helping people living with HIV quit smoking. Positively Smoke Free - Mobile may help patients with HIV quit smoking.
Who can participateInclusion Criteria: * Able to understand and willing to sign a written informed consent document * HIV positive. Documentation of HIV-1 infection by means of any one of the following: * Documentation of HIV diagnosis in the medical record by a licensed health care provider; * Documentation of receipt of antiretroviral therapy (ART) (at least two different medications that do not constitute a prescription for pre-exposure prophylaxis \[PrEP\] or post-exposure prophylaxis \[PEP\]) by a licensed health care provider. Documentation may be a record of an ART prescription in the participant's medical record, a written prescription in the name of the participant for ART, or pill bottles for ART with a label showing the participant's name; * HIV-1 ribonucleic acid (RNA) detection by a licensed HIV
Ages45 Years to 80 Years
SexAll
Lead sponsorAIDS Malignancy Consortium
LocationsLa Jolla, California, United States; Washington D.C., District of Columbia, United States; Tampa, Florida, United States; St Louis, Missouri, United States; New York, New York, United States; New York, New York, United States (+5 more sites)
Start date2023-03-22
NCT IDNCT04949464
Official listinghttps://clinicaltrials.gov/study/NCT04949464

🔍 Search all trials →